Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma is a paper indexed in PICO Portal from OpenAlex.
How many citations does Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma have?
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma has 8,284 citations in the OpenAlex counts PICO Portal stores.
When was Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma published?
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma has 2009 year in the PICO Portal index.
What is the open-access status of Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma?
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma has bronze oa status in the PICO Portal index.
What is the DOI of Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma?
The DOI for Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma is on the source record.
What is the PMID of Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma?
The PMID for Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma is on the source record.
What is the OpenAlex record for Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma?
The OpenAlex for Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma is on the source record.